
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression
Ioannis I. Verginadis, Harris Avgousti, James Monslow, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 6, pp. 940-953
Open Access | Times Cited: 107
Ioannis I. Verginadis, Harris Avgousti, James Monslow, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 6, pp. 940-953
Open Access | Times Cited: 107
Showing 26-50 of 107 citing articles:
Enhancing Tumor Targeted Therapy: The Role of iRGD Peptide in Advanced Drug Delivery Systems
Dragana Nikitovic, Ekaterina V. Kukovyakina, Aikaterini Berdiaki, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3768-3768
Open Access | Times Cited: 6
Dragana Nikitovic, Ekaterina V. Kukovyakina, Aikaterini Berdiaki, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3768-3768
Open Access | Times Cited: 6
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients
Yu Feng, Wenjuan Ma, Yupeng Zang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Yu Feng, Wenjuan Ma, Yupeng Zang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Perivascular niches: critical hubs in cancer evolution
Ada Nowosad, Jean‐Christophe Marine, Panagiotis Karras
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 897-910
Closed Access | Times Cited: 14
Ada Nowosad, Jean‐Christophe Marine, Panagiotis Karras
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 897-910
Closed Access | Times Cited: 14
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican
Aikaterini Berdiaki, Eirini-Maria Giatagana, George N. Tzanakakis, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3549-3549
Open Access | Times Cited: 13
Aikaterini Berdiaki, Eirini-Maria Giatagana, George N. Tzanakakis, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3549-3549
Open Access | Times Cited: 13
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway
Jie Ji, Ziqi Cheng, Jie Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 5
Jie Ji, Ziqi Cheng, Jie Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 5
The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer
Hans Raskov, Shruti Gaggar, Asma Tajik, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2057-2057
Open Access | Times Cited: 12
Hans Raskov, Shruti Gaggar, Asma Tajik, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2057-2057
Open Access | Times Cited: 12
Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers
Raed Sulaiman, Pradip De, Jennifer C. Aske, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 112-112
Open Access | Times Cited: 11
Raed Sulaiman, Pradip De, Jennifer C. Aske, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 112-112
Open Access | Times Cited: 11
CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance
Diane Coursier, Fernando Calvo
Cellular Oncology (2024) Vol. 47, Iss. 4, pp. 1091-1112
Open Access | Times Cited: 4
Diane Coursier, Fernando Calvo
Cellular Oncology (2024) Vol. 47, Iss. 4, pp. 1091-1112
Open Access | Times Cited: 4
Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response
Yuxuan Xiao, Ziyu Wang, Meng Gu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Yuxuan Xiao, Ziyu Wang, Meng Gu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Periostin-mediated NOTCH1 activation between tumor cells and HSCs crosstalk promotes liver metastasis of small cell lung cancer
Linlin Lou, Keren Peng, Shumin Ouyang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Linlin Lou, Keren Peng, Shumin Ouyang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis
Zhenxiong Zhao, Hui Sun, Yingxue Liu, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Zhenxiong Zhao, Hui Sun, Yingxue Liu, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Intratumoral Collagen Deposition Supports Angiogenesis Suggesting Anti‐angiogenic Therapy in Armored and Cold Tumors
Jie Mei, Kai Yang, Xinkang Zhang, et al.
Advanced Science (2025)
Open Access
Jie Mei, Kai Yang, Xinkang Zhang, et al.
Advanced Science (2025)
Open Access
Ribosome Biogenesis, Altered Metabolism and Ribotoxic Stress Response in Pancreatic Ductal Adenocarcinoma Tumor Microenvironment
Sanjib Chaudhary, Jawed A. Siddiqui, Ramesh Pothuraju, et al.
Cancer Letters (2025), pp. 217484-217484
Closed Access
Sanjib Chaudhary, Jawed A. Siddiqui, Ramesh Pothuraju, et al.
Cancer Letters (2025), pp. 217484-217484
Closed Access
Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer
Binbin Cong, Xiaoshan Cao, Wen G. Jiang, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 199-209
Open Access
Binbin Cong, Xiaoshan Cao, Wen G. Jiang, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 199-209
Open Access
Differences in tumor angiogenesis and related factors between lung adenocarcinomas manifesting as pure ground glass opacity and solid nodules
Rirong Qu, Yang Zhang, Shenghui Qin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Rirong Qu, Yang Zhang, Shenghui Qin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progression
Kenny Yu, Zaki Abou-Mrad, Kristof A. Torkenczy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Kenny Yu, Zaki Abou-Mrad, Kristof A. Torkenczy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Collagen remodeling-mediated signaling pathways and their impact on tumor therapy
Zihang Yuan, Bo Lin, Chunlan Wang, et al.
Journal of Biological Chemistry (2025), pp. 108330-108330
Open Access
Zihang Yuan, Bo Lin, Chunlan Wang, et al.
Journal of Biological Chemistry (2025), pp. 108330-108330
Open Access
Cancer ATF4-mediated CD58 endocytosis impairs anti-tumor immunity and immunotherapy
Hanyi Zeng, Jiaping Yu, Haijian Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Hanyi Zeng, Jiaping Yu, Haijian Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Cancer‐Associated Fibroblast Signature Can Predict Prognosis and Therapeutic Responses in Skin Cutaneous Melanoma
Yue Zheng, Weihuan Shao, Tongxin Ge, et al.
Pigment Cell & Melanoma Research (2025) Vol. 38, Iss. 2
Closed Access
Yue Zheng, Weihuan Shao, Tongxin Ge, et al.
Pigment Cell & Melanoma Research (2025) Vol. 38, Iss. 2
Closed Access
Anlotinib may have a therapeutic effect on papillary craniopharyngiomas without the BRAFv600e mutation
Yilamujiang Ainiwan, H. B. Li, Yongjia Zheng, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Yilamujiang Ainiwan, H. B. Li, Yongjia Zheng, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis
Linghui Zou, Peng Xian, Qing Pu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Linghui Zou, Peng Xian, Qing Pu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Blocking ATF4 attenuates pulmonary fibrosis by preventing lung fibroblast activation and macrophage M2 program
Menglin Zou, Weishuai Zheng, Xingxing Hu, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 141890-141890
Closed Access
Menglin Zou, Weishuai Zheng, Xingxing Hu, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 141890-141890
Closed Access
Cascade‐Responsive Nanoprodrug Disrupts Immune‐Fibroblast Communications for Potentiated Cancer Mechanoimmunotherapy
Xin Guan, Yuting Shen, Chong-Ke Zhao, et al.
Advanced Healthcare Materials (2025)
Closed Access
Xin Guan, Yuting Shen, Chong-Ke Zhao, et al.
Advanced Healthcare Materials (2025)
Closed Access
Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: prognostic implications and therapeutic targets
Weihua Song, Yabin Yu, Shuai Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Weihua Song, Yabin Yu, Shuai Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Halofuginone Disrupted Collagen Deposition via mTOR‐eIF2α‐ATF4 Axis to Enhance Chemosensitivity in Ovarian Cancer
Wenxin Li, Yenan Wu, Yanan Zhang, et al.
Advanced Science (2025)
Open Access
Wenxin Li, Yenan Wu, Yanan Zhang, et al.
Advanced Science (2025)
Open Access